enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Endo International - Wikipedia

   en.wikipedia.org/wiki/Endo_International

   Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]

3. McKinsey to pay $650 million after advising opioid maker on ...

   www.aol.com/mckinsey-pay-650-million-advising...

   McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue ... This popular vitamin C serum is on sale for just $10 ...

4. Titan Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Titan_Pharmaceuticals

   In the same month, it also posted approximately $1.7 million in revenue, in large part drawn from its licensing for its European intellectual property rights for Probuphine to the Italian pharmaceutical company Molteni - a leading European opioid manufacturer and also a subsidiary of the German Pharmaceutical juggernaut Merck Group.

5. Consulting firm McKinsey to pay $650 million to resolve US ...

   www.aol.com/consulting-firm-mckinsey-pay-650...

   McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

6. McKinsey & Company agrees to pay $650M for helping ... - AOL

   www.aol.com/mckinsey-company-agrees-pay-650...

   McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...

7. List of off-label promotion pharmaceutical settlements

   en.wikipedia.org/wiki/List_of_off-label...

   Novo Nordisk, a Danish drug manufacturer, agreed to a $25 million settlement to resolve allegations of illegal promotion of the drug NovoSeven, approved by the FDA to treat certain bleeding disorders in hemophiliacs. The government’s complaint alleged numerous off-label uses for which the company promoted the drug, including as a coagulatory ...

8. Insys Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Insys_Therapeutics

   Insys Therapeutics Company type Public Traded as Nasdaq: INSY Industry Pharmaceutical Founded 1990 ; 34 years ago (1990) Founder John Kapoor Fate Bankrupt (2019) Headquarters Chandler, Arizona, U.S. Key people Michael Babich (CEO) Products Subsys (fentanyl) Syndros (Tetrahydrocannabinol) Number of employees 343 (2019) Insys Therapeutics was an American specialty pharmaceutical company based in ...

9. Consulting firm McKinsey to pay $650 million to resolve US ...

   www.aol.com/news/consulting-firm-mckinsey-pay...

   BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...